CLOs on the Move


 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people`s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world`s leading independent biotechnology companies, has reached millions of patients around the world and is ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.amgen.com
  • One Amgen Center Drive
    Thousand Oaks, CA USA 91320
  • Phone: 805.447.1000

Executives

Name Title Contact Details
Dean Patras
Chief People Officer Profile
Dean P
Chief People Officer Profile
Dvora Szego
Assoc. Director Quality Compliance Profile
Paul Johnson
Assoc Vice President, Global Compliance Profile
William Diaz
Chief Antitrust Counsel Profile

Similar Companies

Artisan Orthotic Prosthetic Technologies

Artisan Orthotic Prosthetic Technologies is a Tualatin, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Protein Sciences Corporation

Protein Sciences Corporation is a Meriden, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jnana

Jnana was founded by leading academic scientists, drug developers and investors to develop medicines that transform the lives of patients by targeting the cell`s metabolic gates.

Advanced BioHealing

Advanced BioHealing is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Capstan Therapeutics

Capstan Therapeutics is a biotechnology company dedicated to advancing in vivo cell reprogramming. The core platform technology comprises proprietary targeted lipid nanoparticles conjugated with a recombinant protein binder such as monoclonal antibodies (tLNPs) designed to deliver payloads, including mRNA or gene editing tools, that can reprogram specific cell types in vivo. The platform technology has the potential to generate transformative therapies with applications across a broad range of disease areas, including oncology, autoimmune disorders, fibrosis, and monogenic blood disorders.